1. Medtech Insight
  2. >>Device Area

Exec Chat: Medtronic’s Chan Discusses Future Of Connected Care In A Stressed System

 
• By Reed Miller

Frank Chan, the president of Medtronic’s Patient Monitoring, talked to Medtech Insight about Medtronic’s planned spin-off of its Patient Monitoring business, some lessons from the pandemic, and the potential for digital data to improve patient outcomes.

remote monitoring
• Source: Alamy

Frank Chan, the president of Medtronic’s Patient Monitoring business, is excited about the possibilities for connected care and digital technology to share some of the enormous burdens currently weighing on the people who care for patients.

“We have established a vision, which is universally shared by 4,000 people around the world in my business, and that vision is to transform health monitoring by empowering clinicians and...

Medtronic Plans Spin-Off

Medtronic announced plans to spin off its Patient Monitoring and Respiratory Interventions businesses – part of an ongoing effort to streamline the business. (Also see "Medtronic...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Patient Monitoring

X-ray Regulations Detailed In New FDA Guidance

 
• By Brian Bossetta

The US FDA has published final guidance to provide clarification for industry and agency staff on federal regulations of diagnostic X-ray equipment.

Altoida’s Vision For Alzheimer’s Care Combines Digital Screening, Blood-Based Tests, New Drugs

 
• By Marion Webb

Altoida CEO Marc Jones spoke with Medtech Insight about the company’s investigational digital screening tool for Alzheimer’s and the dire need for better, more accessible precision neurology diagnostics as the global population ages, neurologist shortages worsen, and groundbreaking Alzheimer’s drugs change the treatment paradigm.

FDA Publishes Final Guidance For Sponsors Of Decentralized Clinical Trials

 
• By Brian Bossetta

The US FDA is providing recommendations for sponsors conducting clinical trials outside traditional settings, such as individual homes, mobile research units, and remotely via telehealth participation. The agency says the guidance is part of an overall effort to advance how trials are designed and run.

BD Sees Bright Future For Edwards’ Critical Care, Now BD Advanced Patient Monitoring

 
• By Natasha Barrow

Edwards Lifesciences’ Critical Care business “invented the hemodynamic monitoring category, and its solutions are currently used in more than 10,000 hospitals globally to better understand the cardiovascular condition in real-time for critically ill patients, which helps improve outcomes,” says BD, which sees synergies and new innovation opportunities across the groups’ data sets and platforms. Acquired for $4.2bn cash, Critical Care generated more than $900m in revenue in 2023.

More from Device Area

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System

 
• By Marion Webb

Abbott received the US FDA nod for its Tendyne system, offering a minimally invasive alternative to replace the valves of patients with severe mitral valve disease who are at risk for open-heart surgery.

SAGA Diagnostics Launches Early Breast Cancer MRD Detection Test In US

 
• By Natasha Barrow

SAGA Diagnostics has launched its breast cancer residual and recurrence detection test – Pathlight – in the US. The test’s ultrahigh sensitivity and specificity is rare to see in oncology, the company claimed.

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 
• By Brian Bossetta

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.